Pescovitz Ora H.

Director Pescovitz buys 7,693 shares at $5.89 amid 75.9% decline from 52-week high, stock down 31.8% in 30 days.

Director Ora H. Pescovitz purchased 7,693 shares at $5.89, increasing holdings to 24,329 shares—a 46.2% increase from pre-transaction holdings of 16,636 shares. The purchase occurred when MBX is trading at $6.27, still -75.9% from its 52-week high of $25.98 and down -31.8% over the prior 30 days and -54.2% over 90 days. The company remains unprofitable, with net income of $-18,142,000.00 for its most recent full fiscal year. The transaction represents director participation in the equity of a distressed biotech company trading substantially below historical valuation levels, occurring within a period of sharp price declines.